What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Sell
28
OCX Quote, Financials, Valuation and Earnings
Last price:
$2.64
Seasonality move
:
-17.89%
Day range:
$2.57 - $2.82
52-week range:
$1.92 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.24x
P/B ratio:
5.77x
Volume:
49.6K
Avg. volume:
47.9K
1-year change:
-3.99%
Market cap:
$79.2M
Revenue:
$1.9M
EPS (TTM):
-$4.40
OCX Analysts' Consensus Rating
The 3 analysts providing 12-month price projections for OncoCyte shares anticipate an average target of $4.42, ranging from a low estimate of $4.00 to a high estimate of $5.00. This average target implies a growth of 59.45% compared to the current stock price of $2.77.
Consensus Price Target
$4.42
Highest Price Target
$5.00
Lowest Price Target
$4.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 1 | 1 |
| Hold | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | Hold | Hold | Hold |
OCX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Which Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Is Gartner a Safe Stock to Own?
Gartner (NYSE:IT) is among the world’s largest consulting, research and…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
70
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 44x
Alerts
Buy
57
RGC alert for May 14
Regencell Bioscience Holdings [RGC] is up 10.83% over the past day.
Buy
54
HALO alert for May 14
Halozyme Therapeutics [HALO] is down 4.66% over the past day.
Buy
91
COIN alert for May 14
Coinbase Global [COIN] is up 2.49% over the past day.
